SCHEMBL10469348

SCHEMBL10469348

O=[Si]([O-])[O-].O=[Si]([O-])[O-].[H+].[H+].[Mg+2]

nearest known ligand 0.00

Known targets — ChEMBL curated mechanism

ATP4AATP4BGABBR1GABBR2HMGCR

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3392 0.94
SCHEMBL2678971 0.94
SCHEMBL323472 0.94
Fluoride Ion SCHEMBL5081680 0.88
SCHEMBL1650900 0.88
SCHEMBL222659 0.88
Potassium Ion SCHEMBL3831042 0.88
SCHEMBL10584696 0.88
Water SCHEMBL303037 0.88
SCHEMBL10793069 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100458578-C Salt-like structured silicates as charge control agents CLARIANT GMBH (DE) 2009-02-04 CN disclosed
CN-1399733-A Salt-like structured silicates as charge control agents CLARIANT GMBH (DE) 2003-02-26 CN disclosed
US-4965284-A IMMUNOMODULATORS AMERICAN CYANAMID COMPANY (US) 1990-10-23 US disclosed